Stock Screener App

Frei -

Installieren

8.75

12.15% -1.21

Candel Therapeutics Inc (CADL)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Candel Therapeutics Inc-Aktie (CADL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	0.102
Operating Expenses	23.42% 7.902	10.32	8.861	9.579	9.633
Interest Income/Expense	4.01% 0.646	0.673	0.669	0.644	0.609
Operating Income/Loss	23.42% -7.902	-10.32	-8.861	-9.579	-9.633
Nonoperating Income/Loss	58.94% -0.319	-0.777	0.426	-0.035	0.838
Income/Loss From Continuing Operations Before Tax	25.90% -8.221	-11.10	-8.435	-9.614	-8.795
Income/Loss From Continuing Operations After Tax	25.90% -8.221	-11.10	-8.435	-9.614	-8.795
Net Income/Loss	25.90% -8.221	-11.10	-8.435	-9.614	-8.795
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	188.53K% 29.20	0.0155	28.92	28.92	28.92
Diluted Average Shares	188.53K% 29.20	0.0155	28.92	28.92	28.92
Basic Earnings Per Share	26.32% -0.28	-0.38	-0.29	-0.33	-0.30
Diluted Earnings Per Share	26.32% -0.28	-0.38	-0.29	-0.33	-0.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters